AMPK regulates mechanistic target of rapamycin (mTOR) signalling and inhibits cancer proliferation by downregulating COX‐2 while simultaneously inducing p53 expression [60], as does p53 upregulated modulator of apoptosis (PUMA) [66]. The gene discussed is TP53; the disease is cancer.